The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Gilead Sciences Ireland UC .

Filed returns
27
match these filters
Matching filed returns per period 0 1 2 3 5 Sep–Dec 2017: 1 filed returns Jan–Apr 2018: 1 filed returns May–Aug 2018: 2 filed returns Sep–Dec 2018: 1 filed returns May–Aug 2019: 1 filed returns Sep–Dec 2019: 1 filed returns Jan–Apr 2021: 1 filed returns May–Aug 2021: 1 filed returns Sep–Dec 2021: 1 filed returns Jan–Apr 2022: 1 filed returns May–Aug 2022: 1 filed returns Sep–Dec 2022: 1 filed returns Jan–Apr 2023: 1 filed returns May–Aug 2023: 1 filed returns Sep–Dec 2023: 1 filed returns Jan–Apr 2024: 1 filed returns May–Aug 2024: 1 filed returns Sep–Dec 2024: 3 filed returns Jan–Apr 2025: 1 filed returns May–Aug 2025: 1 filed returns Sep–Dec 2025: 1 filed returns Jan–Apr 2026: 2 filed returns May–Aug 2026: 1 filed returns 2018 2021 2022 2023 2024 2025 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2026 Gilead Sciences Ireland UC Health Meetings to discuss health policy, service capacity and access to medicine (Matters involving public funds) 8 On lobbying.ie
Jan–Apr 2026 Gilead Sciences Ireland UC Health Emails to raise HIV health policy issues (Matters involving public funds) 4 On lobbying.ie
Jan–Apr 2026 Gilead Sciences Ireland UC Health Meetings to discuss health policy and access to medicine (Matters involving public funds) 2 On lobbying.ie
Sep–Dec 2025 Gilead Sciences Ireland UC Health Meetings to discuss HIV health policy and general access to medicine (Matters involving public funds) 2 On lobbying.ie
May–Aug 2025 Gilead Sciences Ireland UC Health Meetings to discuss HIV and Hep-C health-policy (Matters involving public funds) 2 On lobbying.ie
Jan–Apr 2025 Gilead Sciences Ireland UC Health Sent email to DPO's to request meeting to discuss HIV Action Plan (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2024 Gilead Sciences Ireland UC Health Sent email to DPO's to consider, in Programme for Government, a plan of action to reach 2030 HIV healthcare policy goals (Public policy or programme) 7 On lobbying.ie
Sep–Dec 2024 Gilead Sciences Ireland UC Health Sent email to DPO's to consider, in election manifestos, a plan of action to reach 2030 HIV healthcare policy goals (Public policy or programme) 8 On lobbying.ie
Sep–Dec 2024 Gilead Sciences Ireland UC Health Meeting with MEPs at Gilead Manufacturing site in Carrigtwohill, Cork. (Matters involving public funds) 2 On lobbying.ie
May–Aug 2024 Gilead Sciences Ireland UC Health Meetings with political stakeholders to share local company perspective on opportunities and challenges of operating in Ireland including (Matters involving public funds) 3 On lobbying.ie
Jan–Apr 2024 Gilead Sciences Ireland UC Health Draw attention to industry anticipated impact of upcoming EU Pharma legislation on the innovative pharmaceutical industry (Matters involving public funds) 1 On lobbying.ie
Sep–Dec 2023 Gilead Sciences Ireland UC Health HIV, Hepatitis-C & Oncology healthcare policy and access to lifesciences innovation in Ireland (Matters involving public funds) 4 On lobbying.ie
May–Aug 2023 Gilead Sciences Ireland UC Health HIV, Hepatitis-C & Oncology healthcare policy and access to lifesciences innovation in Ireland (Matters involving public funds) 1 On lobbying.ie
Jan–Apr 2023 Gilead Sciences Ireland UC Health HIV, Hepatitis-C & Oncology healthcare policy and access to lifesciences innovation in Ireland (Matters involving public funds) 2 On lobbying.ie
Sep–Dec 2022 Gilead Sciences Ireland UC Health HIV, Hepatitis-C & Oncology healthcare policy and access to lifesciences innovation in Ireland (Matters involving public funds) 7 On lobbying.ie
May–Aug 2022 Gilead Sciences Ireland UC Health HIV, Hepatitis-C & Oncology healthcare policy and access to lifesciences innovation in Ireland (Matters involving public funds) 2 On lobbying.ie
Jan–Apr 2022 Gilead Sciences Ireland UC Health HIV, Hepatitis-C & Oncology healthcare policy and access to lifesciences innovation in Ireland (Matters involving public funds) 4 On lobbying.ie
Sep–Dec 2021 Gilead Sciences Ireland UC Health HIV & hepatitis-C healthcare policy and access to lifesciences innovation in Ireland (Matters involving public funds) 1 On lobbying.ie
May–Aug 2021 Gilead Sciences Ireland UC Health HIV & hepatitis-C healthcare policy and access to lifesciences innovation in Ireland (Matters involving public funds) 4 On lobbying.ie
Jan–Apr 2021 Gilead Sciences Ireland UC Health HIV & hepatitis-C healthcare policy and access to lifesciences innovation in Ireland (Matters involving public funds) 4 On lobbying.ie
Sep–Dec 2019 Gilead Sciences Ireland UC Health Ireland's goal to eliminate Hepatitis-C by 2026 (Matters involving public funds) 3 On lobbying.ie
May–Aug 2019 Gilead Sciences Ireland UC Health Ireland's goal to eliminate Hepatitis-C by 2026 (Matters involving public funds) 1 On lobbying.ie
Sep–Dec 2018 Gilead Sciences Ireland UC Health Hepatitis C and HIV Healthcare (Matters involving public funds) 2 On lobbying.ie
May–Aug 2018 Gilead Sciences Ireland UC Health HIV & Hepatitis C Healthcare Policy in Ireland (Public policy or programme) 1 On lobbying.ie
May–Aug 2018 Gilead Sciences Ireland UC Health HIV & Hepatitis C Healthcare Policy in Ireland (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2018 Gilead Sciences Ireland UC Health HIV & Hepatitis C Health Policy in Ireland (Matters involving public funds) 1 On lobbying.ie
Sep–Dec 2017 Gilead Sciences Ireland UC Health HIV & Hepatitis C health policy in Ireland (Matters involving public funds) 6 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 27 100.0%